Search
Guardant Health Inc
GHAdd to Watchlist
174.880USD
-0.770-0.44%
Close 09-15 16:00（ET）
23.37BMarket Cap
LossP/E TTM
Guardant Health Inc (GH) Stock Price Target & Forecast
Analyst Rating
Based on 27 analysts giving stock ratings to Guardant Health Inc in the past month.
Buy
12 Strong Buy
13 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
192.536USD+22.34%
GH Analyst Recommendation Trends
In the current month, GH has received 13 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. GH average Analyst price target in the last month is 192.536.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
12
12
11
11
11
9
10
10
13
13
11
12
12
13
13
13
2
2
3
3
3
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
27
25
26
26
24
25
25
GH Analyst Rating for Peer Comparison
Updated: Sep 15, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Medtronic PLC
MDT
9
10
11
0
0
30
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Abbott Laboratories
ABT
11
12
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Insulet Corp
PODD
7
8
12
0
0
27
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
Repligen Corp
RGEN
5
14
3
0
0
22
West Pharmaceutical Services Inc
WST
6
12
1
0
0
19
Financial Forecasting
Based on analysts' estimates, GH EPS is projected to reach -0.304 in FY2026Q3, following reported EPS of -0.904 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.70
-0.50
-0.41
-0.30
-0.27
Actual
-1.00
-0.85
-0.90
--
--
Surprise
-42.49%
-72.08%
-121.80%
--
--
FAQs
What is Guardant Health Inc's expected revenue for the next quarter?
Guardant Health Inc's expected revenue is 350.20M.
What is Guardant Health Inc's price target?
Analysts forecast that Guardant Health Inc's price target is USD 192.54, with the highest forecast at USD 225.00 and the lowest forecast at USD 92.41.
How have Guardant Health IncGH's recent earnings per share performed?
The market expectation was USD -0.90, while Guardant Health IncGH's earnings per share (EPS) for the previous quarter was USD -0.85. EPS for the next quarter is expected at USD -0.30.
What is the analyst rating for Guardant Health Inc?
Based on the ratings of Guardant Health Inc's stock from 27 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.